Abstract
We report on three type 2 diabetic patients whose daily basal insulin dose requirements were substantially reduced after switching from insulin detemir to insulin glargine. Meta-analysis of three randomised trials of basal insulin initiation confirmed this increased insulin detemir dose requirement in type 2 patients. Potential explanations are discussed
Original language | English |
---|---|
Pages (from-to) | e24-e26 |
Journal | Diabetes Research and Clinical Practice |
Volume | 84 |
Issue number | 2 |
DOIs |
|
Publication status | Published - 2009 |